Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:46:03.974Z.
Calculation as of: 2026-10-06T16:46:03.974Z.
Quote observation: 2026-10-06T16:45:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a5ea7848df566bb1fba137e14a23bd7a424b67da13a14cf2752e181034030ce3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$32.27M
Free Cash Flow Yield
N/A
TTM Avg
25.34%
3Y Avg
24.30%
5Y Avg
24.30%
Market Cap
$31.36M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.64M
Free Cash Flow Yield
4.72%
TTM Avg
6.20%
3Y Avg
5.96%
5Y Avg
5.96%
Market Cap
$33.15M
Free Cash Flow Yield
N/A
TTM Avg
0.20%
3Y Avg
0.20%
5Y Avg
0.20%
Market Cap
$31.44M
Free Cash Flow Yield
6.15%
TTM Avg
6.00%
3Y Avg
9.05%
5Y Avg
10.35%
Market Cap
$30.94M
Free Cash Flow Yield
N/A
TTM Avg
51.68%
3Y Avg
51.68%
5Y Avg
51.68%
Market Cap
$33.66M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30.69M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartBeam, Inc. (BEAT) | $32.62M | N/A | N/A | N/A | N/A |
| Scilex Holding Company (SCLX)vs › | $32.27M | N/A | 25.34% | 24.30% | 24.30% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | N/A | N/A | N/A | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $32.64M | 4.72% | 6.20% | 5.96% | 5.96% |
| EUDA Health Holdings Limited (EUDA)vs › | $33.15M | N/A | 0.20% | 0.20% | 0.20% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 6.15% | 6.00% | 9.05% | 10.35% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.94M | N/A | 51.68% | 51.68% | 51.68% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.66M | N/A | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.69M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $34.20M | N/A | 11.85% | 7.93% | 7.46% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
